Isotretinoin
- PMID: 30247824
- Bookshelf ID: NBK525949
Isotretinoin
Excerpt
Isotretinoin is an oral retinoid prescribed to manage severe nodular acne unresponsive to conventional therapies, including systemic antibiotics. This activity reviews isotretinoin’s FDA-approved indications, off-label uses, and pharmacological effects on sebaceous gland function. The discussion also addresses isotretinoin’s mechanism of action, pharmacokinetics, and administration considerations, ensuring healthcare professionals understand key factors influencing therapeutic success and patient safety. Adverse drug reactions, contraindications, monitoring requirements, and potential drug-drug interactions are also reviewed to support risk mitigation strategies during isotretinoin therapy. Additional attention is given to clinical toxicology and safety measures, especially concerning pregnancy prevention and long-term monitoring.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Stein Gold LF, Tan JKL, Tollefson MM, Weiss JS, Wu PA, Zaenglein AL, Han JM, Barbieri JS. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 May;90(5):1006.e1-1006.e30. - PubMed
-
- Huang TC, Chang CH, Hsiao PF, Hsu CK, Lin CY, Wu CS, Yeh SP, Tsai TF. Cutaneous T-cell lymphoma: Consensus on diagnosis and management in Taiwan. J Formos Med Assoc. 2024 Nov 03; - PubMed
Publication types
LinkOut - more resources
Full Text Sources